Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging
Roche Presents Results of Evrysdi (risdiplam) in RAINBOWFISH Study for the Treatment of Neuromuscular Disorder at WMS 2021
Shots:
- Roche launches Elecsys EBV immunoassay panel in countries accepting the CE mark. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG, and Elecsys EBV EBNA IgG to detect Abs specific for the infection stage
- The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, resulting in potentially faster diagnosis for patients
- The EBV panel can be used in other acute infections, such as missed HIV infections. Additionally, Roche will submit the regulatory filing to the US FDA for the EBV panel in future
Click here to read full press release/ article | Ref: Roche | Image: Krauthammer